Quetiapine: A Review of its Clinical Potential in the Management of Psychotic Symptoms in Parkinson's Disease

ISSN： 1172-7047

Source： CNS Drugs, Vol.14, Iss.2, 2000-08, pp. : 157-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Psychotic symptoms in Parkinson’s disease: pathophysiology and management

By Bosboom JLW Wolters ECh

Expert Opinion on Drug Safety, Vol. 3, Iss. 3, 2004-05 ,pp. : 209-220

Informa Healthcare

Access to resources Recommend Favorite

Enoxaparin: A Review of its Clinical Potential in the Management of Coronary Artery Disease

By Noble S. Spencer C.M.

Drugs, Vol. 56, Iss. 2, 1998-08 ,pp. : 259-272

Adis International

Access to resources Recommend Favorite

Ropinirole: A Review of its Use in the Management of Parkinson's Disease

By Matheson A.J. Spencer C.M.

Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. : 115-137

Adis International

Access to resources Recommend Favorite

Tolcapone: A Review of its Use in the Management of Parkinson's Disease

By Gillian M. Keating Katherine A. Lyseng-Williamson

CNS Drugs, Vol. 19, Iss. 2, 2005-01 ,pp. : 165-184

Adis International

Access to resources Recommend Favorite

Rasagiline: A Review of its Use in the Management of Parkinson's Disease

By Oldfield Vicki Keating Gillian M. Perry Caroline M.

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1725-1747

Adis International

Access to resources Recommend Favorite